The full content of Annals is available to subscribers

Subscribe/Learn More  >
Updates |

Update in Endocrinology

Janet A. Schlechte, MD; and Robert Kreisberg, MD
[+] Article, Author, and Disclosure Information

From the University of Iowa, Iowa City, Iowa; and Baptist Health System, Birmingham, Alabama. Requests for Reprints: Janet Schlechte, MD, Clinical Research Center, Room 157, MRF, University of Iowa, Iowa City, IA 52242. Current Author Addresses: Dr. Schlechte: Clinical Research Center, Room 157, MRF, University of Iowa, Iowa City, IA 52242.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1998;128(5):378-385. doi:10.7326/0003-4819-128-5-199803010-00007
Text Size: A A A

Advances in endocrinology in 1996 occurred in many areas. First, another drug was added to the growing list of agents used to treat type 2 diabetes mellitus. Second, an additional agent was found to be effective in decreasing low-density lipoprotein (LDL) cholesterol and triglyceride levels and thus may provide more effective prevention of atherosclerotic vascular disease. Third, the bisphosphonates, especially the oral drug alendronate, were shown to benefit patients with a broad array of bone diseases. In addition, 1996 was a year of studies that contributed to the debate over the use of human growth hormone. Finally, estrogen therapies were shown not only to delay bone loss in postmenopausal women but also to actually increase bone mineral density.

First Page Preview

View Large
First page PDF preview


Grahic Jump Location
Figure 1.
Therapeutic approach to type 2 diabetes mellitus.1c

* Typical goal would be a hemoglobin A level of 0.07 or less.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Comparison of effects of four HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors.
Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Update on Bone Health in Pediatric Chronic Disease. Endocrinol Metab Clin North Am 2016;45(2):433-41.
Epidemiology of Fractures in Diabetes. Calcif Tissue Int Published online Jul 21, 2016;
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.